Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy.

Leukemia & lymphoma·2026
Same author

Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male.

Oxford medical case reports·2026
Same author

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Blood advances·2026
Same author

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Blood cancer journal·2026
Same author

Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma.

Blood·2026
Same author

Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Blood advances·2026
Same journal

Molecular Relapse After a Second Treatment-Free Remission Attempt Following Asciminib in Chronic Myeloid Leukemia: A Case Report.

Case reports in hematology·2026
Same journal

Common Clonal Origin of Core-Binding-Factor AML in Both Donor and Recipient Following Kidney Transplantation.

Case reports in hematology·2026
Same journal

T-Cell Lymphoma With Sarcoid-Like Reaction and Secondary Myelofibrosis: A Unique Case Report and Literature Review.

Case reports in hematology·2026
Same journal

The Challenge of Differentiating Mixed Histiocytosis: A Case Report.

Case reports in hematology·2026
Same journal

Ivermectin Treatment for <i>Strongyloides stercoralis-</i>Associated Recurrence of Nongastric MALT Lymphoma.

Case reports in hematology·2026
Same journal

Allogeneic Stem Cell Transplantation in Patients With Mixed Chimerism Following Double Cord Blood Transplantation: A Case Report.

Case reports in hematology·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Extranodal Male Genital Involvement With Diffuse Large B-Cell Lymphoma.

James J Fradin1, Kavanya Feustel2, Mehdi Hamadani2

  • 1Division of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu.

Case Reports in Hematology
|May 22, 2026
PubMed
Summary
This summary is machine-generated.

Primary penile diffuse large B-cell lymphoma (DLBCL) is rare and difficult to diagnose. A case report details successful treatment of advanced penile DLBCL in an elderly patient using a modified regimen including polatuzumab vedotin.

Related Experiment Videos

Last Updated: May 23, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Area of Science:

  • Oncology
  • Hematology
  • Rare Cancers

Background:

  • Primary penile diffuse large B-cell lymphoma (DLBCL) is an exceptionally rare extranodal lymphoma.
  • Diagnosis can be challenging due to nonspecific symptoms, potentially leading to delayed treatment.

Purpose of the Study:

  • To report a case of advanced penile DLBCL in an elderly patient.
  • To review existing literature on penile DLBCL presentation and treatment.
  • To highlight the efficacy of novel agents in treating frail patients with advanced disease.

Main Methods:

  • Case report of an 84-year-old male with Stage IVB activated B-cell type DLBCL.
  • Treatment with dose-reduced rituximab, cyclophosphamide, doxorubicin, prednisone, and polatuzumab vedotin (modified R-mini-CHOP).
  • Literature review of previously reported penile DLBCL cases.

Main Results:

  • The patient achieved a partial metabolic response with negative minimal residual disease despite advanced-stage disease.
  • Literature review identified patterns in penile DLBCL presentation and treatment strategies.
  • Polatuzumab vedotin demonstrated potential in treating elderly/frail patients with advanced penile DLBCL.

Conclusions:

  • Penile lesions require a broad differential diagnosis to ensure timely and appropriate treatment.
  • Novel therapeutic agents like polatuzumab vedotin offer promising options for elderly or frail patients with advanced penile DLBCL.
  • This case underscores the importance of considering rare presentations of lymphoma and adapting treatment regimens for vulnerable populations.